[1]	The tax effect of the revaluation of property, plant and equipment of joint ventures and associates was $99,415 for the year ended June 30, 2023.
[2]	The tax effect of the revaluation of property, plant and equipment was $703,087 for the year ended June 30, 2023.

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023
OPERATING ACTIVITIES
(Loss)/ Profit for the year	$ (58,845,253)	$ 7,288,983	$ 20,174,599
Adjustments to reconcile profit to net cash flows
Income tax	1,273,616	3,778,615	(1,068,652)
Financial results	55,335,675	34,785,325	35,078,018
Depreciation of property, plant and equipment	5,990,809	5,763,249	4,833,274
Amortization of intangible assets	11,154,731	12,113,107	10,991,433
Depreciation of leased assets	5,036,703	3,418,956	3,565,894
Transactional expenses	3,992,662	1,119,525	4,183,916
Share-based incentive and stock options	4,386,688	14,134,885	3,415,108
Share of profit or loss of joint ventures and associates	1,126,312	(4,049,508)	(1,198,628)
Loss of participation in joint ventures and associates			133,079
Gain from a bargain purchase		(1,032,327)
Provisions for contingencies	335,773	367,126	221,008
Allowance for impairment of trade debtors	7,123,716	753,428	1,327,385
Allowance for obsolescence	1,547,723	586,515	1,066,777
Initial recognition and changes in the fair value of biological assets	(1,764,863)	45,746	(610,554)
Changes in the net realizable value of agricultural products after harvest	1,541,204	2,385,069	4,351,433
Gain on sale of equipment and intangible assets	(7,751,311)	(125,464)	(74,593)
Working capital adjustments
Trade receivables	25,499,217	(46,681,153)	(56,867,123)
Other receivables	(916,362)	(4,967,150)	(11,475,717)
Income and minimum presumed income taxes	(6,997,089)	4,782,508	(16,154,083)
Inventories and biological assets	34,910,189	14,176,656	(11,066,489)
Trade and other payables	(32,039,367)	14,234,092	(4,501,398)
Employee benefits and social security	(1,166,946)	(2,289,095)	1,258,673
Deferred revenue and advances from customers	(128,698)	(21,087,704)	13,322,769
Income taxes paid		(853,299)	(4,072,347)
Interest collected	120,568	2,747,398	5,378,413
Inflation effects on working capital adjustments	139,914	321,103	376,597
Net cash flows generated by operating activities	49,905,611	41,716,586	2,588,792
INVESTMENT ACTIVITIES
Proceeds from sale of property, plant and equipment	390,381	336,726	137,357
Net cash received from business combination		37,508	4,373,265
Proceeds from financial assets	19,270,288	888,140	1,316,980
Investment in financial assets	(11,182,107)	(7,208,218)	(8,990,083)
Purchase of property, plant and equipment	(5,642,162)	(9,789,574)	(11,360,469)
Capitalized development expenditures	(8,614,448)	(11,855,766)	(10,753,047)
Purchase of intangible assets	(350,843)	(1,137,071)	(449,673)
Net cash flows used by investing activities	(6,128,891)	(28,728,255)	(25,725,670)
FINANCING ACTIVITIES
Proceeds from borrowings	266,390,032	135,818,247	79,817,888
Repayment of borrowings and financed payments	(288,454,302)	(112,614,437)	(16,744,956)
Interest payments	(18,932,563)	(24,724,436)	(18,046,961)
Other financial payments	(3,208,933)	(2,746,945)	(4,767,378)
Purchase of own shares	(926,899)	(734,388)	(2,996,947)
Leased assets payments	(5,501,387)	(4,879,108)	(3,855,517)
Cash dividend distributed by subsidiary	(72,051)	(174,800)	(452,129)
Net cash flows (used by)/ generated by financing activities	(50,706,103)	(10,055,867)	32,954,000
Net (decrease)/ increase in cash and cash equivalents	(6,929,383)	2,932,464	9,817,122
Inflation effects on cash and cash equivalents	2,557	(31,918)	(101,767)
Cash and cash equivalents as of beginning of the year	44,473,270	48,129,194	33,475,266
Effect of exchange rate changes on cash and equivalents	(4,851,365)	(6,556,470)	4,938,573
Cash and cash equivalents as of the end of the year	$ 32,695,079	$ 44,473,270	$ 48,129,194

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)	Jun. 30, 2025	Jun. 30, 2024
CURRENT ASSETS
Cash and cash equivalents	$ 32,695,079	$ 44,473,270
Other financial assets	2,040,038	11,695,528
Trade receivables	165,859,933	207,320,974
Other receivables	15,861,981	18,298,672
Recoverable income tax	1,864,817	655,691
Inventories	87,611,269	125,929,768
Biological assets	2,378,380	294,134
Total current assets	308,311,497	408,668,037
NON-CURRENT ASSETS
Other financial assets	58	634,553
Trade receivables	2,506,834
Other receivables	23,660,530	17,957,121
Recoverable income tax	17,995	10,889
Deferred tax assets	4,916,980	9,698,860
Investments in joint ventures and associates	39,371,264	39,786,353
Investment properties	570,324	560,783
Property, plant and equipment	74,575,386	74,573,278
Intangible assets	181,173,079	176,893,136
Goodwill	112,163,432	112,163,432
Right of use asset	16,377,701	11,601,752
Total non-current assets	455,333,583	443,880,157
Total assets	763,645,080	852,548,194
CURRENT LIABILITIES
Trade and other payables	96,432,604	168,732,469
Borrowings	119,728,126	136,747,198
Employee benefits and social security	6,174,012	7,340,958
Deferred revenue and advances from customers	4,282,668	3,923,140
Income tax payable	452,800	4,825,271
Consideration for acquisition	1,761,274	4,617,281
Secured notes	102,270,445
Lease liabilities	6,884,042	3,122,778
Total current liabilities	337,985,971	329,309,095
NON-CURRENT LIABILITIES
Trade and other payables	48,481,726
Borrowings	38,198,026	42,104,882
Deferred revenue and advances from customers	1,436,912	1,925,138
Joint ventures and associates	1,007,678	296,455
Deferred tax liabilities	30,122,920	34,995,791
Provisions	1,267,572	1,255,702
Consideration for acquisition	397,774	2,309,234
Secured notes		80,809,686
Lease liabilities	9,527,939	8,161,359
Total non-current liabilities	130,440,547	171,858,247
Total liabilities	468,426,518	501,167,342
EQUITY
Equity attributable to owners of the parent	265,444,568	315,041,257
Non-controlling interest	29,773,994	36,339,595
Total equity	295,218,562	351,380,852
Total equity and liabilities	$ 763,645,080	$ 852,548,194